Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PJP vs LYFIX overlap: 15% of top holdings shared

Bottom line

How much do PJP and LYFIX overlap?

15% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 20.9% of PJP's assets and 13.0% of LYFIX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

PJPLYFIX
Weight overlap (top 25)15%
Shared holdings5
Weight in shared holdings20.9%13.0%
Total positions3362
Expense ratio0.58%1.41%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings PJP and LYFIX have in common

Holding% of PJP% of LYFIXOverlap
AbbVie Inc.5.48%1.95%1.95%
Amgen Inc.5.33%1.83%1.83%
Gilead Sciences, Inc.4.53%5.53%4.53%
Jazz Pharmaceuticals PLC2.79%1.87%1.87%
Biogen Inc.2.75%1.80%1.80%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PJP

  1. Invesco Private Prime Fund — 7.93%
  2. Abbott Laboratories — 5.67%
  3. Johnson & Johnson — 5.18%
  4. Merck & Co., Inc. — 5.06%
  5. Eli Lilly and Co. — 5.02%
  6. Corcept Therapeutics Inc. — 4.96%
  7. Pfizer Inc. — 4.50%
  8. Amneal Pharmaceuticals, Inc. — 3.75%
  9. Invesco Private Government Fund — 3.73%
  10. Liquidia Corp. — 3.66%
  11. Travere Therapeutics, Inc. — 3.30%
  12. Ligand Pharmaceuticals Inc. — 3.20%
  13. Regeneron Pharmaceuticals, Inc. — 3.14%
  14. Harmony Biosciences Holdings, Inc. — 3.06%
  15. Bristol-Myers Squibb Co. — 2.94%

Only in LYFIX

  1. Vertex Pharmaceuticals Inc — 5.33%
  2. Astrazeneca Plc — 4.63%
  3. First American Funds Inc — 4.26%
  4. Roivant Sciences Ltd — 3.67%
  5. Argenx Se — 3.59%
  6. Neurocrine Biosciences Inc — 3.51%
  7. Incyte Corp — 3.51%
  8. Axsome Therapeutics Inc — 3.43%
  9. Apogee Therapeutics Inc — 3.28%
  10. Ionis Pharmaceuticals Inc — 2.62%
  11. Ascendis Pharma A/s — 2.62%
  12. Insmed Inc — 2.60%
  13. Protagonist Therapeutics Inc — 2.41%
  14. Personalis Inc — 2.27%
  15. Rhythm Pharmaceuticals Inc — 2.25%

Asset mix

Asset typePJPLYFIX
Stocks99.9%95.8%
Cash & short-term funds11.8%4.3%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryPJPLYFIX
US106.5%76.0%
IE5.2%2.4%
NL—4.7%
GB—4.6%
BM—3.7%
FR—2.8%
DK—2.6%
KY—1.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do PJP and LYFIX overlap?
About 15% by weight. 5 securities appear in both funds' top 25 holdings; they make up 20.9% of PJP's assets and 13.0% of LYFIX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do PJP and LYFIX have in common?
The largest shared holdings are Gilead Sciences, Inc., AbbVie Inc., Jazz Pharmaceuticals PLC, Amgen Inc., Biogen Inc..
Should I own both PJP and LYFIX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, PJP or LYFIX?
LYFIX is broader, with 62 positions versus 33 for PJP. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.